Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
43.9 USD | +0.45% | -2.20% | -14.51% |
05-01 | HSBC Adjusts Price Target on Bristol-Myers Squibb to $45 From $50 | MT |
05-01 | Editas Medicine, Bristol-Myers Squibb Extend Alpha-Beta T Cell Collaboration | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.51% | 88.58B | |
+27.08% | 681B | |
+21.85% | 556B | |
-4.96% | 361B | |
+17.24% | 325B | |
+5.43% | 285B | |
+13.68% | 235B | |
+3.65% | 199B | |
-11.12% | 189B | |
-4.03% | 157B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Bristol Myers Squibb : Grail Teams Up With Amgen, AstraZeneca, Bristol Myers Squibb to Evaluate Cancer Detection Technology